Biotech | February 17, 2022
PerkinElmer’s SIRION Biotech and CRG to develop diabetes gene therapy
Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy
Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy
The collaboration will leverage EdiGene’s expertise in high-throughput genome editing screening and Neukio’s strength in the development and manufacturing of induced pluripotent stem cell (iPSC) and natural killer cell (NK Cell)
The Vasostrict brand market had U.S. sales of approximately US $ 878.5 million MAT for the most recent twelve months ending in December 2021 according to IQVIA Health
Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug
Vabysmo is the only injectable eye medicine approved simultaneously in the US for wet AMD and DME, with flexible dosing regimens based on patient need
The drug is to be supplied in 105 low and middle-income countries and 10 Indian firms are on the list
The extended collaboration will provide services relating to small molecules for both Forbion and BGV portfolio companies active in the biopharmaceutical space
This test analyses samples in VTM directly without the need for RNA extraction step
Under the terms of the agreement, Mammoth Biosciences will receive an upfront payment of USD 40 million, potential future payments of more than one billion USD upon successful achievement of certain research, development, and commercial milestones
Innovative market development collaboration also signed, expanding the availability of select Novartis oncology products in regions across China currently not covered by Novartis
Subscribe To Our Newsletter & Stay Updated
